Cornelia B Landersdorfer (Cornelia Landersdorfer)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 43

Top Venues

Antimicrobial agents and chemotherapy

mSystems

The Journal of antimicrobial chemotherapy

Pharmaceutics

Monash University (Parkville Campus)

Institute for Biomedical and Pharmaceutical Research (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Monash University (Parkville Campus) Aug 22 2016

Australia

Senior Lecturer :: Centre for Medicine Use and Safety, Monash Institute of Pharmaceutical Sciences

Monash University (Parkville Campus) Jan 01 2014 - Aug 21 2016

Australia

NHMRC Career Development Fellow :: Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences

Monash University (Parkville Campus) Aug 21 2011 - Dec 31 2013

Australia

Senior Research Fellow :: Centre for Medicine Use and Safety

Ordway Research Institute

United States

Scientist

Institute for Clinical Pharmacodynamics

United States

Scientist

State University of New York at Buffalo

United States

Postdoc :: Pharmaceutics

Education History

Institute for Biomedical and Pharmaceutical Research

Germany

PHD

Julius-Maximilians-Universität Würzburg

Germany

PHD

Publications

Jessica R Tait, Dovile Anderson, Roger L Nation, Darren John Creek, Cornelia B Landersdorfer
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa . Antimicrobial agents and chemotherapy (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jessica R Tait, Dovile Anderson, Roger L Nation, Darren John Creek, Cornelia B Landersdorfer
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa . Antimicrobial agents and chemotherapy 68 (4) (2024)
Maytham Hussein, Muhammad Bilal Hassan Mahboob, Jessica R Tait, James L Grace, Véronique Montembault, Laurent Fontaine, John F Quinn, Tony Velkov, Michael R Whittaker, Cornelia B Landersdorfer
Providing insight into the mechanism of action of cationic lipidated oligomers using metabolomics. mSystems 9 (5) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Maytham Hussein, Muhammad Bilal Hassan Mahboob, Jessica R Tait, James L Grace, Véronique Montembault, Laurent Fontaine, John F Quinn, Tony Velkov, Michael R Whittaker, Cornelia B Landersdorfer
Providing insight into the mechanism of action of cationic lipidated oligomers using metabolomics. mSystems 9 (5) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy (2024)
Maytham Hussein, Muhammad Bilal Hassan Mahboob, Jessica R Tait, James L Grace, Véronique Montembault, Laurent Fontaine, John F Quinn, Tony Velkov, Michael R Whittaker, Cornelia B Landersdorfer
Providing insight into the mechanism of action of cationic lipidated oligomers using metabolomics. mSystems (2024)
Maytham Hussein, Muhammad Bilal Hassan Mahboob, Jessica R Tait, James L Grace, Véronique Montembault, Laurent Fontaine, John F Quinn, Tony Velkov, Michael R Whittaker, Cornelia B Landersdorfer
Providing insight into the mechanism of action of cationic lipidated oligomers using metabolomics. mSystems 9 (5) (2024)
Jessica R Tait, Dovile Anderson, Roger L Nation, Darren John Creek, Cornelia B Landersdorfer
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa . Antimicrobial agents and chemotherapy 68 (4) (2024)
Jieqiang Zhou, Yuli Qian, Yinzhi Lang, Yongzhen Zhang, Xun Tao, Bartolome Moya, Alaa R M Sayed, Cornelia B Landersdorfer, Eunjeong Shin, Carolin Werkman, Nicholas M Smith, Tae Hwan Kim, Monika Kumaraswamy, Beom Soo Shin, Brian T Tsuji, Robert A Bonomo, Richard E Lee, Juergen B Bulitta
Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation. Antimicrobial agents and chemotherapy 68 (3) (2024)
Jessica R Tait, Dovile Anderson, Roger L Nation, Darren John Creek, Cornelia B Landersdorfer
Identifying and mathematically modeling the time-course of extracellular metabolic markers associated with resistance to ceftolozane/tazobactam in Pseudomonas aeruginosa . Antimicrobial agents and chemotherapy 68 (4) (2024)
Guohua An, C Buddy Creech, Nan Wu, Roger L Nation, Kenan Gu, Demet Nalbant, Natalia Jimenez-Truque, William H Fissell, Stephanie Rolsma, Pratish C Patel, Amy Watanabe, Nicholas Fishbane, Carl M J Kirkpatrick, Cornelia B Landersdorfer, Patricia Winokur
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis. Antimicrobial agents and chemotherapy (2023)
Guohua An, C Buddy Creech, Nan Wu, Roger L Nation, Kenan Gu, Demet Nalbant, Natalia Jimenez-Truque, William H Fissell, Stephanie Rolsma, Pratish C Patel, Amy Watanabe, Nicholas Fishbane, Carl M J Kirkpatrick, Cornelia B Landersdorfer, Patricia Winokur
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis. Antimicrobial agents and chemotherapy 67 (1) (2023)
Syaza Y Binte Abu Bakar, Malinda Salim, Andrew J Clulow, Susanne Seibt, Cornelia B Landersdorfer, Donna T Geddes, Kevin R Nicholas, Ben J Boyd
Construction of a Synthetic Colostrum Substitute and Its Protection of Intestinal Cells against Inflammation in an In Vitro Model of Necrotizing Enterocolitis. ACS applied materials & interfaces (2023)
Guohua An, C Buddy Creech, Nan Wu, Roger L Nation, Kenan Gu, Demet Nalbant, Natalia Jimenez-Truque, William Fissell, Pratish C Patel, Nicholas Fishbane, Amy Watanabe, Stephanie L Rolsma, Carl M J Kirkpatrick, Cornelia B Landersdorfer, Patricia Winokur
Population pharmacokinetics and target attainment analyses to identify a rational empirical dosing strategy for cefepime in critically ill patients. The Journal of antimicrobial chemotherapy (2023)
Guohua An, C Buddy Creech, Nan Wu, Roger L Nation, Kenan Gu, Demet Nalbant, Natalia Jimenez-Truque, William H Fissell, Stephanie Rolsma, Pratish C Patel, Amy Watanabe, Nicholas Fishbane, Carl M J Kirkpatrick, Cornelia B Landersdorfer, Patricia Winokur
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis. Antimicrobial agents and chemotherapy 67 (1) (2023)
Charalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, Eleni Volakli, Stavroula Ilia, Evangelos Gikas, Helen Gika, Maria Sdougka, Roger L Nation, Emmanuel Roilides
Correction for Antachopoulos et al., "Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher than Recommended Doses". Antimicrobial agents and chemotherapy 67 (2) (2023)
Charalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, Eleni Volakli, Stavroula Ilia, Evangelos Gikas, Helen Gika, Maria Sdougka, Roger L Nation, Emmanuel Roilides
Correction for Antachopoulos et al., "Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher than Recommended Doses". Antimicrobial agents and chemotherapy 67 (2) (2023)
Charalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, Eleni Volakli, Stavroula Ilia, Evangelos Gikas, Helen Gika, Maria Sdougka, Roger L Nation, Emmanuel Roilides
Correction for Antachopoulos et al., "Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher than Recommended Doses". Antimicrobial agents and chemotherapy (2023)
Guohua An, C Buddy Creech, Nan Wu, Roger L Nation, Kenan Gu, Demet Nalbant, Natalia Jimenez-Truque, William H Fissell, Stephanie Rolsma, Pratish C Patel, Amy Watanabe, Nicholas Fishbane, Carl M J Kirkpatrick, Cornelia B Landersdorfer, Patricia Winokur
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis. Antimicrobial agents and chemotherapy 67 (1) (2023)
Jessica R Tait, Marina Harper, Sara Cortés-Lara, Kate E Rogers, Carla López-Causapé, Thomas R Smallman, Yinzhi Lang, Wee Leng Lee, Jieqiang Zhou, Juergen B Bulitta, Roger L Nation, John D Boyce, Antonio Oliver, Cornelia B Landersdorfer
Ceftolozane-Tazobactam against Pseudomonas aeruginosa Cystic Fibrosis Clinical Isolates in the Hollow-Fiber Infection Model: Challenges Imposed by Hypermutability and Heteroresistance. Antimicrobial agents and chemotherapy (2023)
Guohua An, C Buddy Creech, Nan Wu, Roger L Nation, Kenan Gu, Demet Nalbant, Natalia Jimenez-Truque, William H Fissell, Stephanie Rolsma, Pratish C Patel, Amy Watanabe, Nicholas Fishbane, Carl M J Kirkpatrick, Cornelia B Landersdorfer, Patricia Winokur
Evaluation of Empirical Dosing Regimens for Meropenem in Intensive Care Unit Patients Using Population Pharmacokinetic Modeling and Target Attainment Analysis. Antimicrobial agents and chemotherapy 67 (1) (2023)
Charalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, Eleni Volakli, Stavroula Ilia, Evangelos Gikas, Helen Gika, Maria Sdougka, Roger L Nation, Emmanuel Roilides
Correction for Antachopoulos et al., "Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher than Recommended Doses". Antimicrobial agents and chemotherapy 67 (2) (2023)
Courtney L Luterbach, Hong-Qiang Qiu, Patrick O Hanafin, Rajnikant Sharma, Joseph Piscitelli, Feng-Chang Lin, Jenni Ilomaki, Eric Cober, Robert A Salata, Robert C Kalayjian, Richard R Watkins, Yohei Doi, Keith S Kaye, Roger L Nation, Robert A Bonomo, Cornelia B Landersdorfer, David Van Duin, Gauri G Rao, null null
A Systems-Based Analysis of Mono- and Combination Therapy for Carbapenem-Resistant Klebsiella pneumoniae Bloodstream Infections. Antimicrobial agents and chemotherapy 66 (10) (2022)
Jessica R Tait, Timothy C Barnett, Kate E Rogers, Wee Leng Lee, Madhu Page-Sharp, Laurens Manning, Ben J Boyd, Jonathan R Carapetis, Roger L Nation, Cornelia B Landersdorfer
Penicillin G concentrations required for prophylaxis against Group A Streptococcus infection evaluated using a hollow fibre model and mathematical modelling. The Journal of antimicrobial chemotherapy 77 (7) (2022)
Hajira Bilal, Jessica R Tait, Yinzhi Lang, Jieqiang Zhou, Phillip J Bergen, Anton Y Peleg, Juergen B Bulitta, Antonio Oliver, Roger L Nation, Cornelia B Landersdorfer
Simulated Intravenous versus Inhaled Tobramycin with or without Intravenous Ceftazidime Evaluated against Hypermutable Pseudomonas aeruginosa via a Dynamic Biofilm Model and Mechanism-Based Modeling. Antimicrobial agents and chemotherapy 66 (3) (2022)
Jessica R Tait, Hajira Bilal, Kate E Rogers, Yinzhi Lang, Tae-Hwan Kim, Jieqiang Zhou, Steven C Wallis, Juergen B Bulitta, Carl M J Kirkpatrick, David L Paterson, Jeffrey Lipman, Phillip J Bergen, Jason Alexander Roberts, Roger L Nation, Cornelia B Landersdorfer
Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model. Antibiotics (Basel, Switzerland) 11 (1) (2022)
Dina Zheng, Phillip J Bergen, Cornelia B Landersdorfer, Elizabeth B Hirsch
Differences in fosfomycin resistance mechanisms between Pseudomonas aeruginosa and Enterobacterales. Antimicrobial agents and chemotherapy (2021)
Courtney Brusamarello, Andrew J Daley, Xiao Zhu, Cornelia B Landersdorfer, Amanda Gwee
How important are MIC determination methods when targeting vancomycin levels in patients with Staphylococcus aureus infections? The Journal of antimicrobial chemotherapy 76 (6) (2021)
Charalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, Eleni Volakli, Stavroula Ilia, Evangelos Gikas, Helen Gika, Maria Sdougka, Roger L Nation, Emmanuel Roilides
Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended Doses. Antimicrobial agents and chemotherapy 65 (6) (2021)
Hajira Bilal, Phillip J Bergen, Jessica R Tait, Steven C Wallis, Anton Y Peleg, Jason Alexander Roberts, Antonio Oliver, Roger L Nation, Cornelia B Landersdorfer
Clinically Relevant Epithelial Lining Fluid Concentrations of Meropenem with Ciprofloxacin Provide Synergistic Killing and Resistance Suppression of Hypermutable Pseudomonas aeruginosa in a Dynamic Biofilm Model. Antimicrobial agents and chemotherapy 64 (7) (2020)
Elizabeth C Smith, Hunter V Brigman, Jadyn C Anderson, Christopher L Emery, Tiffany E Bias, Phillip J Bergen, Cornelia B Landersdorfer, Elizabeth B Hirsch
Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa Isolates. Journal of clinical microbiology 58 (10) (2020)
Rajbharan Yadav, Phillip J Bergen, Kate E Rogers, Carl M J Kirkpatrick, Steven C Wallis, Yuling Huang, Juergen B Bulitta, David L Paterson, Jeffrey Lipman, Roger L Nation, Jason Alexander Roberts, Cornelia B Landersdorfer
Meropenem-Tobramycin Combination Regimens Combat Carbapenem-Resistant Pseudomonas aeruginosa in the Hollow-Fiber Infection Model Simulating Augmented Renal Clearance in Critically Ill Patients. Antimicrobial agents and chemotherapy 64 (1) (2019)
Vanessa E Rees, Juergen B Bulitta, Antonio Oliver, Roger L Nation, Cornelia B Landersdorfer
Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling. Pharmaceutics 11 (9) (2019)
Roger L Nation, Cornelia B Landersdorfer
Optimization of dosing regimens of intravenous colistin in patients with cystic fibrosis: What data are required? Pediatric pulmonology 54 (10) (2019)
James L Grace, Maite Amado, Janet C Reid, Alysha G Elliott, Cornelia B Landersdorfer, Nghia Phuoc Truong, Kristian Kempe, Matthew A Cooper, Thomas P Davis, Véronique Montembault, Sagrario Pascual, Laurent Fontaine, Xukai Jiang, John F Quinn, Michael Raymond Whittaker
An optimised Cu(0)-RDRP approach for the synthesis of lipidated oligomeric vinyl azlactone: toward a versatile antimicrobial materials screening platform. Journal of materials chemistry. B 7 (43) (2019)
Juergen B Bulitta, Yuanyuan Jiao, Cornelia B Landersdorfer, Dhruvitkumar S Sutaria, Xun Tao, Eunjeong Shin, Rainer Höhl, Gerhard Bringmann, Ulrich Stephan, Fritz Sörgel
Comparable Bioavailability and Disposition of Pefloxacin in Patients with Cystic Fibrosis and Healthy Volunteers Assessed via Population Pharmacokinetics. Pharmaceutics 11 (7) (2019)
Hajira Bilal, Phillip J Bergen, Tae Hwan Kim, Seung Eun Chung, Anton Y Peleg, Antonio Oliver, Roger L Nation, Cornelia B Landersdorfer
Synergistic Meropenem-Tobramycin Combination Dosage Regimens against Clinical Hypermutable Pseudomonas aeruginosa at Simulated Epithelial Lining Fluid Concentrations in a Dynamic Biofilm Model. Antimicrobial agents and chemotherapy 63 (11) (2019)

Cornelia B Landersdorfer.css-eqlu8i{font-size:small;padding-left:4px;} (Cornelia Landersdorfer)

Publication Activity (10 Years)

Top Topics

Top Venues

Cornelia B Landersdorfer (Cornelia Landersdorfer)